Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Chronic hepatitis and other liver disease 

Chronic hepatitis and other liver disease
Chapter:
Chronic hepatitis and other liver disease
Author(s):

Pierre Van Damme

, Tinne Lernout

, Koen Van Herck

, Rui T. Marinho

, Raymundo Paraná

, and Daniel Shouval

DOI:
10.1093/med/9780199661756.003.0216
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 22 January 2022

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are major risk factors in the development of hepatocellular carcinoma (HCC) either by inducing cirrhosis or by direct oncogenic effects, representing a major burden worldwide. Around 400 million people are chronically infected with HBV or HCV and approximately 1 million people die each year (~2.7% of all deaths) from causes related to viral hepatitis, most commonly cirrhosis and HCC. Alcohol consumption is responsible for increased illness and death and is associated with an increased risk of a number of cancers. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis are chronic liver diseases associated with the metabolic syndrome. This tends to take epidemic proportions in the Western population, and to constitute a major health problem in the near future. On the other hand, obesity seems to be also a strong oncogenic condition, in particular for HCC.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.